Back to Royal Bank of Canada Royal Bank of Canada

VIRVIR

Showing 8 of 27 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Vir Biotechnology, Inc.

Yes. Royal Bank of Canada holds 14,910 shares of VIR (Vir Biotechnology), worth $153,000, as of its Q2 2026 13F filing. It reduced the position by 445 shares (-2.9%) from Q1 2026. Royal Bank of Canada has held VIR in every 13F on record since Q4 2019, 27 quarterly filings.

Current Value

$153,000

Current Shares

14,910

Total Value Change

+$59,000

Total Shares Change

+2,459

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
14,910
-2.9%
$153,0000.0%$10.19
0
2026-Q1
Increased
15,355
+223.1%
$138,0000.0%$8.96
24
2025-Q4
Decreased
4,752
-99.3%
$29,0000.0%$6.03
0
2025-Q3
Increased
716,388
+1.3%
$4.1M0.0%$5.71
27
2025-Q2
Increased
707,226
+2927.3%
$3.6M0.0%$5.04
43
2025-Q1
Increased
23,362
+47.1%
$152,0000.0%$6.48
21
2024-Q4
Increased
15,886
+27.6%
$117,0000.0%$7.34
19
2024-Q3
Increased
12,451
+19.6%
$94,0000.0%$7.53
17

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used